Polar Asset Management Partners’s Bellevue Life Sciences Acquisition Corp. Rights BLACR Stock Holding History

Polar Asset Management Partners’s Portfolio BLACR Stock Details BLACR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-360,000	Closed	-$46.8K	–	808
2024 Q4	$46.8K	Hold	360,000	–	–	﹤0.01%	555
2024 Q3	$39.3K	Hold	360,000	–	–	﹤0.01%	564
2024 Q2	$43.4K	Hold	360,000	–	–	﹤0.01%	539
2024 Q1	$54K	Hold	360,000	–	–	﹤0.01%	573
2023 Q4	$54K	Hold	360,000	–	–	﹤0.01%	551
2023 Q3	$82.8K	Hold	360,000	–	–	﹤0.01%	584
2023 Q2	$68.8K	Hold	360,000	–	–	﹤0.01%	664
2023 Q1	$64.8K	Buy	+360,000	New	+$55.9K	﹤0.01%	746

Polar Asset Management Partners's BLACR Position: Q1 2025 in Review

Polar Asset Management Partners sold out of Bellevue Life Sciences Acquisition Corp. Rights (BLACR) in Q1 2025, closing a stake of 360,000 shares — an estimated $46.8K sold.

Polar Asset Management Partners first reported a position in BLACR in Q1 2023 and held it in 8 quarters. The position peaked at $82.8K in Q3 2023. 0 funds tracked by Wall St. Rank hold BLACR as of Q1 2025.

Polar Asset Management Partners reported no remaining Bellevue Life Sciences Acquisition Corp. Rights position as of Q1 2025 after selling out during the quarter.
Polar Asset Management Partners sold 360,000 Bellevue Life Sciences Acquisition Corp. Rights shares in Q1 2025, an estimated $46.8K.
Polar Asset Management Partners first reported a position in Bellevue Life Sciences Acquisition Corp. Rights in Q1 2023 and held it in 8 quarters.
Polar Asset Management Partners's Bellevue Life Sciences Acquisition Corp. Rights position peaked at $82.8K in Q3 2023.
0 funds tracked by Wall St. Rank held Bellevue Life Sciences Acquisition Corp. Rights as of Q1 2025.

Based on Polar Asset Management Partners's 13F filing for Q1 2025, filed 15 May 2025.